My Passport
News and Commentary education Live Coronavirus Dashboard
S&P 500 ETF
0.00%
NASDAQ ETF
0.00%
Dow Jones ETF
0.00%


OpenAI, Anthropic, SpaceX IPOs Could End Big...
Adobe Pauses Price Hikes For 'Short-Term' AI...
Trump Says Iran 'Better Get Their Act Togethe...
GameStop Didn't Make Money With Its Bitcoin B...
Value Investors Question SpaceX's Record IPO:...
Google Sounds Alarm On Active Oracle PeopleSo...
Chinese Customers Can Now Order NVIDIA's Vera...
SpaceX's IPO Could Spark A Venture Capital Fr...
The Rise of the Solo General Partner Investor

While modern day venture capital originated in the 1940s, the very first iteration of venture capital (VC) investments--where a general partner (GP) investments capital on behalf of a limited partner (LP)--dates all the way back to the early 1600s with the founding of East India...

  • How are Higher Rates Impacting the Housi...
  • Quantitative Tightening: How the Fed Co...
  • Should Investors Worry About Inflation?
  • How Semiconductors are Made and Why its...
  • What Are NFTs?
    • Inflation: What is it and How to Protect From...
    Short Squeezes Could Lead to Market Dislocati...
    How Google and Facebook Antitrust Lawsuits Co...
    Vaccine News Triggers Growth to Value Rotatio...
    Energy
    Materials
    Industrial
    Finance
    Consumer D...
    Consumer S...
    Informatio...
    Telecommun...
    Health Car...
    Utilities
    Oil
    Gold
    ETFs IPOs Ratings
     
    S&P 500 ETF
    0.00%
    NASDAQ ETF
    0.00%
    Dow Jones ETF
    0.00%
    Search
    News and Commentary
    Education
    Market
    ETFs
    IPOs
    Ratings
    Newsfeed
    My passport
    Login
    Sign up

    ACADIA PHARMACEUTICALS INC (NASDAQ: ACAD)

    Overview
    current price
    $21.09
    $21.09
    change
    -0.30 | -1.40%
    -0.30 | -1.40%
    Yesterday's Close
    21.39
    open
    21.49
    volume
    0.75 M
    30d. avg volume.
    1.54 M
    1 day
    21.05 - 21.55
    52 weeks
    19.69 - 28.35
    p/e
    9.54
    beta
    0.8355
    market cap
    3.61 B
    dividend yield
    0.00%
    Industry
    -
    acad by TradingView
    News and Commentary
    After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stol... U.S. drug wholesaler Cencora Inc (
    Neuro Drug Stocks Rise Following Intra-CellularTherapies' Drug Approval One indisputable trend about the modern world is that people are living longer. In 1950, the average lifespan for an American was 68 years old. Today, it's 78. One result of a lo...
    Market Summary: Oil Prices Rise After Saudi Arabia Names New Energy Minister Following lack of major U.S. economic data or earnings reports being released early in the week, much of market focus has been toward overseas data and the global economy. The U....
    StockTwits
    StockTwits
    Most Shared
    Starbucks Stock Holds Steady As Investors Digest Extensive Corporate Restructuring Plan
    IBM Is Chasing A '$1 Trillion Value Creation Engine' — And It's Spending $15 Billion To Get There
    Consumers Are Feeling The Squeeze — And That Could Be Walmart's Biggest Advantage
    Most Popular
    Meta's $125 Billion AI Bet Might Be The Capex Trap Of The Decade
    AI's Memory Shortage Runs Into 2028 — Goldman Stays Bullish On SanDisk, Samsung, SK Hynix
    Starbucks Stock Holds Steady As Investors Digest Extensive Corporate Restructuring Plan
    popular tags
    Earnings
    Apple
    Amazon
    Coronavirus
    Tesla
    Coronavirus Impact
    Google
    China
    Covid-19
    mobile iOS
    social Facebook Twitter Youtube Linkedin Rss Google News
    Passport to Wall Street About Us Contact Advertise Privacy Policy Terms of Service
    Sign Up
    © 2026 Passport to Wall Street
    Quotes are at least 20 minutes delayed

    Join now and unlock premium features

    Already Have An Account?